A Providence City Council member is calling for a complete …
The Rhode Department of Environmental Management and the U.S. …
Advertisement
RI gets $1.2M from Avandia case
Drug maker admits no wrongdoing
Updated: Sunday, 18 Nov 2012, 9:10 AM EST
Published : Sunday, 18 Nov 2012, 9:10 AM EST
PROVIDENCE, R.I. (AP) -- Rhode Island is getting about $1.2 million to settle claims that British drug maker GlaxoSmithKline LLC deceptively promoted the diabetes drug Avandia.
The payment is part of a $90 million settlement between GlaxoSmithKline and attorneys general from 38 different states.
Attorney General Peter Kilmartin and colleagues claim the company misrepresented Avandia's cardiovascular risks and safety profile. The agreement requires the company to reform its marketing practices and to publicize information about any company-sponsored clinical trials on its diabetes drugs.
GlaxoSmithKline doesn't admit any wrongdoing. A spokeswoman says the company firmly believes it acted responsibly in testing, marketing and monitoring the safety of Avandia.
Ground rules for posting comments: No profanity or personal attacks. Please comment on the subject of the story itself. If you do not follow these rules, we will remove your post. Keep it civil, folks!
Our commenting section is powered by IntenseDebate. If you registered for an account but didn't receive a verification e-mail, check your spam folder or click here for more information. For additional technical help, click here.
Email This
Print This
View Story on a Single PageAdvertisement
Advertisement